Patent · US Active

Method for determining the haemoglobin content of an erythroid cell

US12345718B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 6, 2021
Grant dateJul 1, 2025
Priority date
Expiry dateFeb 24, 2044

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention concerns a method for determining, by flow cytometry, the hemoglobin content of each erythroid cell of a set of erythroid cells. This method applies in particular to determining the hemoglobin content of each red blood cell of a set of red blood cells. The invention also concerns a method for determining the amount of red blood cells transfused into a patient and for monitoring the therapeutic efficacy of a treatment for sickle cell disease or β-thalassemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.